AAN GUIDELINES Bundle

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis

AAN GUIDELINES Product Bundle brought to you by Guideline Central.

Issue link: https://eguideline.guidelinecentral.com/i/1512415

Contents of this Issue

Navigation

Page 3 of 5

Table 1. Risk Factor-Control During Follow-up Increased Risk No Increased Risk Point Estimate a Confidence Systolic blood pressure (SBP) (out of target) 1.7 High Mean arterial pressure (MAP) (out of target) 2.8 Moderate Diastolic blood pressure (DBP) (out of target) 2.2 Moderate Strict blood pressure control plus low distal flow status 6.2 Low Total cholesterol (TC) (out of target) 2.1 Moderate TC/HDL ratio (out of target) 1.9 Moderate Non- high-density lipoprotein cholesterol (HDL-C) (out of target) 1.4 Low Low-density lipoprotein cholesterol (LDL-C) (out of target) 1.3 Low Physical activity (out of target) 6.7 High Alcohol use (out of target) 1.8 Moderate Hemoglobin A1c (HbA1C) (out of target) 2.3 Moderate a e evidence is insufficient to support or refute that failure to achieve a body mass index (BMI) target and smoking cessation predicts an increased risk of recurrent stroke. Predictors of Recurrent Stroke or Death in Patients With s-ICAS Table 2. Modifiable Risk Factors at Baseline Increased Risk No Increased Risk Point Estimate a Confidence SBP 1.3 Low DBP (lower) 0.9 Moderate Hypertension (no history) 0.9 Low HDL-C 1.0 Low Glucose >200 mg/dL 2.0 Moderate History of diabetes 1.6 Moderate Elevated triglycerides 1.6 Moderate Physical activity (less active) 1.1 Low BMI 1.4 Low Smoker 1.0 Low History of carotid artery disease 0.95 Low Failure of anti-thrombotic therapy 1.0 Low a ere is insufficient evidence to support or refute the following modifiable risk factors in predicting an increased risk of recurrent stroke: baseline HbA1c, baseline TC, a history of peripheral vascular disease, a history of dyslipidemia, baseline LDL-C, elevated lipoprotein (a), metabolic syndrome, alcohol use, high-sensitivity C-reactive protein (hs-CRP), and a positive myocardial single-photon emission computerized tomography (SPECT) scan. Treatment

Articles in this issue

view archives of AAN GUIDELINES Bundle - Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis